Adaptive Biotechnologies (ADPT) Change in Acquisitions & Divestments (2018 - 2026)

Adaptive Biotechnologies (ADPT) has 9 years of Change in Acquisitions & Divestments data on file, last reported at $48.8 million in Q1 2026.

• Quarterly Change in Acquisitions & Divestments fell 37.02% year-over-year to $48.8 million in Q1 2026, while the trailing twelve-month figure through Mar 2026 was $193.9 million (down 36.14% YoY) and the FY2025 annual result came in at $222.6 million, down 31.65% from the prior year.
• Change in Acquisitions & Divestments rose to $48.8 million in Q1 2026 per ADPT's latest filing, from $39.1 million in the prior quarter.
• The five-year high for Change in Acquisitions & Divestments was $155.0 million in Q1 2023, with the low at $35.0 million in Q2 2022.
• Average Change in Acquisitions & Divestments over 5 years is $86.2 million, with a median of $77.5 million recorded in 2025.
• Year-over-year, Change in Acquisitions & Divestments tumbled 75.78% in 2022 and jumped 301.15% in 2023.
• Adaptive Biotechnologies' Change in Acquisitions & Divestments stood at $70.0 million in 2022, then soared by 80.63% to $126.5 million in 2023, then tumbled by 47.04% to $67.0 million in 2024, then tumbled by 41.62% to $39.1 million in 2025, then rose by 24.77% to $48.8 million in 2026.
• Business Quant data shows ADPT's Change in Acquisitions & Divestments at $48.8 million in Q1 2026, $39.1 million in Q4 2025, and $50.9 million in Q3 2025.